Success Metrics

Clinical Success Rate
92.3%

Based on 24 completed trials

Completion Rate
92%(24/26)
Active Trials
8(19%)
Results Posted
21%(5 trials)
Terminated
2(5%)

Phase Distribution

Ph not_applicable
17
40%
Ph phase_2
1
2%
Ph phase_1
1
2%

Phase Distribution

1

Early Stage

1

Mid Stage

0

Late Stage

Phase Distribution19 total trials
Phase 1Safety & dosage
1(5.3%)
Phase 2Efficacy & side effects
1(5.3%)
N/ANon-phased studies
17(89.5%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

92.3%

24 of 26 finished

Non-Completion Rate

7.7%

2 ended early

Currently Active

8

trials recruiting

Total Trials

42

all time

Status Distribution
Active(10)
Completed(24)
Terminated(2)
Other(6)

Detailed Status

Completed24
unknown6
Recruiting6
Not yet recruiting2
Terminated2
Active, not recruiting2

Development Timeline

Analytics

Development Status

Total Trials
42
Active
8
Success Rate
92.3%
Most Advanced
Phase 2

Trials by Phase

Phase 11 (5.3%)
Phase 21 (5.3%)
N/A17 (89.5%)

Trials by Status

not_yet_recruiting25%
terminated25%
unknown614%
recruiting614%
completed2457%
active_not_recruiting25%

Recent Activity

Clinical Trials (42)

Showing 20 of 42 trialsScroll for more
NCT06473506Not Applicable

Group A Streptococcus Saliva Study

Active Not Recruiting
NCT07556367Not Applicable

Post-Radiation Oral Health in Underserved Head and Neck Cancer Patients

Recruiting
NCT04367545Not Applicable

Development of a Molecular Diagnostic Strategy for SARS-CoV2 Based on Saliva in the Context of the COVID-19 Pandemic

Completed
NCT06213532Not Applicable

CONNECTing to LungCare

Recruiting
NCT07378540

Evaluation of Microbial Status in Gastritis Patients in Different Periodontal Conditions

Completed
NCT07275489

CHOICE KERGUELEN 2 : Consequences of Longterm Confinement on Immunity in the Sub-Antarctic Islands : Follow-up of Volunteers on the Kerguelen Islands

Recruiting
NCT07065253

CHOICE KERGUELEN 1: Consequences of Longterm Confinement on Immunity in the Sub-Antarctic Islands: Inclusion of Volunteers Before Departure to the Kerguelen Islands

Completed
NCT07262606Not Applicable

Salivary Mitofusin-1 Levels in Periodontitis: Associations With Disease Severity, Smoking, and Treatment Response

Recruiting
NCT06876064

National Cohort of Subjects at Risk of Developing Rheumatoid Arthritis

Not Yet Recruiting
NCT06482957

Cohort to Augment the Understanding of Sarcoma Survivorship Across the Lifespan

Recruiting
NCT04427280

Cancer: Rapid Diagnostics and Immune Assessment for SARS-CoV-2 (COVID-19)

Completed
NCT04613375

PCV13 Effectiveness Study Against Hospitalised VT Pneumococcal CAP in Adults 60 Years and Older

Completed
NCT06990919Not Applicable

Evaluation of the Stress Levels of Children and Their Parents

Completed
NCT04979455

Risk Factors for Exertional Heat Illness

Active Not Recruiting
NCT03735745Not Applicable

Transdisciplinary Oral/Oropharyngeal Cancer Research & Care in Head and Neck Cancer (TORCH)

Completed
NCT06701214

The Clonal Hematopoiesis & Inflammation in Vasculature Registry and Biorepository

Recruiting
NCT06432855Not Applicable

Genetic Determinants of the Antiviral Immune Response in Oceanian Populations

Not Yet Recruiting
NCT02821832Phase 2

Using Biomarkers to Predict TB Treatment Duration

Completed
NCT06183385Not Applicable

Detection of Saliva by Immunoaffinity and Mass Spectrometry

Unknown
NCT04460638

SARS-CoV2 (COVID-19) Diagnosis in Human Saliva by MALDI-TOF MS Profiling

Completed

Drug Details

Intervention Type
DIAGNOSTIC TEST
Total Trials
42